Advisors Asset Management, Inc. Bio N Tech Se Transaction History

Advisors Asset Management, Inc.

$5.1 Billion
Q1 2025

A detailed history of Advisors Asset Management, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 557 shares of BNTX stock, worth $60,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares

557

Previous 846 34.16%

Holding current value

$60,696

Previous $96,000 47.92%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$91.06 - $126.88 $26,316 - $36,668	-289 Reduced 34.16%	557 $50,000
Q4 2024 Feb 10, 2025	SELL	$99.72 - $122.68 $88,750 - $109,185	-890 Reduced 51.27%	846 $96,000
Q3 2024 Nov 08, 2024	SELL	$78.36 - $124.66 $12,772 - $20,319	-163 Reduced 8.58%	1,736 $206,000
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $110,012 - $140,829	-1,369 Reduced 41.89%	1,899 $152,000
Q1 2024 May 14, 2024	SELL	$88.96 - $112.35 $52,486 - $66,286	-590 Reduced 15.29%	3,268 $301,000
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $319,639 - $396,429	-3,516 Reduced 47.68%	3,858 $407,000
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $339,129 - $428,655	-3,306 Reduced 30.96%	7,374 $795,000
Q1 2023 May 12, 2023	BUY	$122.57 - $153.67 $65,329 - $81,906	533 Added 5.25%	10,680 $1.33 Million
Q3 2022 Nov 08, 2022	SELL	$127.65 - $183.11 $97,779 - $140,262	-766 Reduced 3.6%	20,489 $2.76 Million
Q2 2022 Aug 08, 2022	BUY	$123.25 - $186.24 $157,020 - $237,269	1,274 Added 6.38%	21,255 $3.17 Million
Q1 2022 May 17, 2022	BUY	$126.25 - $231.85 $199,727 - $366,786	1,582 Added 8.6%	19,981 $3.41 Million
Q4 2021 Feb 15, 2022	BUY	$216.64 - $362.52 $356,156 - $595,982	1,644 Added 9.81%	18,399 $4.74 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $460,253 - $999,559	2,235 Added 15.39%	16,755 $4.57 Million
Q2 2021 Jul 30, 2021	BUY	$113.32 - $241.49 $332,480 - $708,531	2,934 Added 25.32%	14,520 $3.25 Million
Q1 2021 May 07, 2021	BUY	$85.73 - $119.5 $533,669 - $743,887	6,225 Added 116.12%	11,586 $1.27 Million
Q4 2020 Feb 12, 2021	BUY	$72.71 - $129.54 $389,798 - $694,463	5,361 New	5,361 $437,000

Others Institutions Holding BNTX

# of Institutions

340

Shares Held

40M

Call Options Held

1.43M

Put Options Held

1.54M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Bio N Tech Se Transaction History